Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring

Lotta Mäkinen; Markus Vähä-Koskela; Matilda Juusola; Harri Mustonen; Krister Wennerberg; Jaana Hagström; Pauli Puolakkainen; Hanna Seppänen

doi:10.3390/cancers14030525

Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring

Lotta Mäkinen, Markus Vähä-Koskela, Matilda Juusola, Harri Mustonen, Krister Wennerberg, Jaana Hagström, Pauli Puolakkainen, Hanna Seppänen

Forskningsoutput: Tidskriftsbidrag › Översiktsartikel › Peer review

Originalspråk	engelska
Artikelnummer	525
Tidskrift	Cancers
Volym	14
Nummer	3
Antal sidor	22
ISSN	2072-6694
DOI	https://doi.org/10.3390/cancers14030525
Status	Publicerad - feb. 2022
MoE-publikationstyp	A2 Granska artikel i en vetenskaplig tidskrift

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.3390/cancers14030525

cancers-14-00525Slutlig publicerad version, 2,33 MBLicens: CC BY

Citera det här

Mäkinen, L., Vähä-Koskela, M., Juusola, M., Mustonen, H., Wennerberg, K., Hagström, J., Puolakkainen, P., & Seppänen, H. (2022). Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring. Cancers, 14(3), [525]. https://doi.org/10.3390/cancers14030525

@article{d189bb99db6b4b8c8ad1aef1855522ad,

title = "Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring",

keywords = "3122 Cancers, PANCREATIC DUCTAL ADENOCARCINOMA, ORGANOIDS, cancer precision medicine, Drug Combinations, pancreatic ductal adenocarcinoma, organoid, cancer precision medicine, drug combinations, SINGLE-CELL ANALYSIS, IN-VITRO, DUCTAL ADENOCARCINOMA, STEM-CELL, TUMOR, GEMCITABINE, EXPANSION, SUBTYPES, SURVIVAL, STATE",

author = "Lotta M{\"a}kinen and Markus V{\"a}h{\"a}-Koskela and Matilda Juusola and Harri Mustonen and Krister Wennerberg and Jaana Hagstr{\"o}m and Pauli Puolakkainen and Hanna Sepp{\"a}nen",

year = "2022",

month = feb,

doi = "10.3390/cancers14030525",

language = "English",

volume = "14",

journal = "Cancers",

issn = "2072-6694",

publisher = "MDPI",

number = "3",

}

TY - JOUR

T1 - Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring

AU - Mäkinen, Lotta

AU - Vähä-Koskela, Markus

AU - Juusola, Matilda

AU - Mustonen, Harri

AU - Wennerberg, Krister

AU - Hagström, Jaana

AU - Puolakkainen, Pauli

AU - Seppänen, Hanna

PY - 2022/2

Y1 - 2022/2

KW - 3122 Cancers

KW - PANCREATIC DUCTAL ADENOCARCINOMA

KW - ORGANOIDS

KW - cancer precision medicine

KW - Drug Combinations

KW - pancreatic ductal adenocarcinoma

KW - organoid

KW - cancer precision medicine

KW - drug combinations

KW - SINGLE-CELL ANALYSIS

KW - IN-VITRO

KW - DUCTAL ADENOCARCINOMA

KW - STEM-CELL

KW - TUMOR

KW - GEMCITABINE

KW - EXPANSION

KW - SUBTYPES

KW - SURVIVAL

KW - STATE

U2 - 10.3390/cancers14030525

DO - 10.3390/cancers14030525

M3 - Review Article

VL - 14

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 3

M1 - 525

ER -